Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Total Non-Current Liabilities (2021 - 2025)

Core Scientific's Total Non-Current Liabilities history spans 5 years, with the latest figure at $3.1 billion for Q3 2025.

  • For Q3 2025, Total Non-Current Liabilities rose 382.59% year-over-year to $3.1 billion; the TTM value through Sep 2025 reached $3.1 billion, up 382.59%, while the annual FY2024 figure was $1.3 billion, 0.96% up from the prior year.
  • Total Non-Current Liabilities for Q3 2025 was $3.1 billion at Core Scientific, up from $1.7 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $3.1 billion in Q3 2025 and bottomed at $12.9 million in Q1 2021.
  • The 5-year median for Total Non-Current Liabilities is $1.3 billion (2022), against an average of $1.1 billion.
  • The largest annual shift saw Total Non-Current Liabilities skyrocketed 11709.1% in 2022 before it plummeted 86.43% in 2023.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $1.0 billion in 2021, then rose by 17.41% to $1.2 billion in 2022, then increased by 7.76% to $1.3 billion in 2023, then rose by 0.96% to $1.3 billion in 2024, then surged by 131.47% to $3.1 billion in 2025.
  • Per Business Quant, the three most recent readings for CORZ's Total Non-Current Liabilities are $3.1 billion (Q3 2025), $1.7 billion (Q2 2025), and $1.4 billion (Q1 2025).